February 27, 2020 / 12:41 PM / a month ago

BRIEF-Concert Pharmaceuticals Reports Qtrly Loss Per Share $0.86

Feb 27 (Reuters) - Concert Pharmaceuticals Inc:

* CONCERT PHARMACEUTICALS REPORTS 2019 FINANCIAL RESULTS AND PROVIDES UPDATE ON CLINICAL PROGRAMS

* QTRLY LOSS PER SHARE $0.86

* Q4 EARNINGS PER SHARE VIEW $-0.79, REVENUE VIEW $13330.00 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below